Trial Profile
Study of the effect of tofogliflozin on glucose and lipid metabolism abnormality after the test meal loading
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 02 Jun 2017
Price :
$35
*
At a glance
- Drugs Tofogliflozin (Primary)
- Indications Type 2 diabetes mellitus
- Focus Pharmacodynamics
- 31 May 2017 Status changed from active, no longer recruiting to completed.
- 14 Jul 2015 Status changed from recruiting to active, no longer recruiting as reported by University Hospital Medical Information Network - Japan record.
- 02 Dec 2014 New trial record